172 related articles for article (PubMed ID: 23716607)
1. Comparison of genomes of Brucella melitensis M28 and the B. melitensis M5-90 derivative vaccine strain highlights the translation elongation factor Tu gene tuf2 as an attenuation-related gene.
Wang F; Qiao Z; Hu S; Liu W; Zheng H; Liu S; Zhao X; Bu Z
Infect Immun; 2013 Aug; 81(8):2812-8. PubMed ID: 23716607
[TBL] [Abstract][Full Text] [Related]
2. Complete genome sequences of Brucella melitensis strains M28 and M5-90, with different virulence backgrounds.
Wang F; Hu S; Gao Y; Qiao Z; Liu W; Bu Z
J Bacteriol; 2011 Jun; 193(11):2904-5. PubMed ID: 21478357
[TBL] [Abstract][Full Text] [Related]
3. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
4. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
[TBL] [Abstract][Full Text] [Related]
6. Genomic analysis of the original Elberg Brucella melitensis Rev.1 vaccine strain reveals insights into virulence attenuation.
Salmon-Divon M; Yeheskel A; Kornspan D
Virulence; 2018; 9(1):1436-1448. PubMed ID: 30139304
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic analysis of Brucella melitensis vaccine strain M5 provides insights into virulence attenuation.
Jiang H; Du P; Zhang W; Wang H; Zhao H; Piao D; Tian G; Chen C; Cui B
PLoS One; 2013; 8(8):e70852. PubMed ID: 23967122
[TBL] [Abstract][Full Text] [Related]
8. Identification of Brucella melitensis Rev.1 vaccine-strain genetic markers: Towards understanding the molecular mechanism behind virulence attenuation.
Issa MN; Ashhab Y
Vaccine; 2016 Sep; 34(41):4884-4891. PubMed ID: 27595444
[TBL] [Abstract][Full Text] [Related]
9. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
[TBL] [Abstract][Full Text] [Related]
10. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
[TBL] [Abstract][Full Text] [Related]
11. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
[TBL] [Abstract][Full Text] [Related]
12.
Verdiguel-Fernández L; Oropeza-Navarro R; Ortiz A; Robles-Pesina MG; Ramírez-Lezama J; Castañeda-Ramírez A; Verdugo-Rodríguez A
J Microbiol Biotechnol; 2020 Apr; 30(4):497-504. PubMed ID: 31986561
[TBL] [Abstract][Full Text] [Related]
13. Brucella melitensis M5-90Δbp26 as a potential live vaccine that allows for the distinction between natural infection and immunization.
Li T; Tong Z; Huang M; Tang L; Zhang H; Chen C
Can J Microbiol; 2017 Aug; 63(8):719-729. PubMed ID: 28482164
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate.
Wang Z; Niu JR; Wang XL; Wu TL; Cheng J; Lu L; Wu QM
Microbes Infect; 2014 Aug; 16(8):633-9. PubMed ID: 25043564
[TBL] [Abstract][Full Text] [Related]
15. Insights into
Zhang H; Wang B; Wu W; Deng X; Shao Z; Yi J; Wang Z; Yang N; Wang Y; Wang Y; Chen C
Can J Microbiol; 2020 May; 66(5):351-358. PubMed ID: 32040345
[TBL] [Abstract][Full Text] [Related]
16. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
Uslu A; Erganis O
Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
[TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
18. Genome sequences of three live attenuated vaccine strains of Brucella species and implications for pathogenesis and differential diagnosis.
Wang Y; Ke Y; Wang Z; Yuan X; Qiu Y; Zhen Q; Xu J; Li T; Wang D; Huang L; Chen Z
J Bacteriol; 2012 Nov; 194(21):6012-3. PubMed ID: 23045513
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transcriptional change of B. melitensis M5-90 after macrophage infection highlights the role of ribosome gene L31 in virulence.
Xu D; Zhao J; Jiang L; Song J; Zong S; Yan X; Liu H; Zhang H; Hu S; Bu Z
Vet Microbiol; 2021 Feb; 253():108951. PubMed ID: 33373884
[TBL] [Abstract][Full Text] [Related]
20. Deep-sequencing analysis of the mouse transcriptome response to infection with Brucella melitensis strains of differing virulence.
Wang F; Hu S; Liu W; Qiao Z; Gao Y; Bu Z
PLoS One; 2011; 6(12):e28485. PubMed ID: 22216095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]